Zepbound 12.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQU4R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,327
Award facts
- Contract value 100% obligated
- $36,326.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded Amerisourcebergen Drug Corp a delivery order valued at $36,326.50 on January 14, 2026, for the supply of Zepbound 12.5 mg/0.5 mL pens. This firm fixed-price contract, with an ultimate completion date of January 15, 2026, represents a small-value pharmaceutical delivery executed through Amerisourcebergen's existing indefinite delivery contract with DLA Troop Support Medical. The contract carries no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with performance occurring at its corporate office location in the same city. The company operates as a subsidiary of Cencora, Inc., which holds the overarching $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical through December 2026.
This delivery order exemplifies the pharmaceutical supply chain support that Amerisourcebergen provides to federal military healthcare systems. Zepbound, a GLP-1 receptor agonist used for weight management, represents the type of specialty medication included in the comprehensive global pharmaceutical support vehicle maintained by Cencora through its DLA contract. The delivery order structure and firm fixed-price arrangement are consistent with the company's extensive portfolio of federal medical product deliveries across multiple therapeutic domains, demonstrating its established capability to meet Department of Defense healthcare procurement requirements efficiently and cost-effectively.
Quick answers
Who was awarded contract SPE2DR26FQU4R?
SPE2DR26FQU4R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FQU4R worth?
The government has obligated $36,327 on SPE2DR26FQU4R.
Is contract SPE2DR26FQU4R an order under another contract?
Yes. SPE2DR26FQU4R is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQU4R competed?
The extent of competition for SPE2DR26FQU4R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award